Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 1179392 NEW YORK, NY
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$249,849
-$18,152 QoQ
Shares Held
40,825
-19.4% QoQ
Ownership
0.238%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 43 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. VRCA ranks #285 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in VRCA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $249,849 40,825
2026-03-31 $268,001 50,662
2025-12-31 $982,391 118,218
2025-06-30 $46,265 87,293
2025-03-31 $39,193 88,674
2024-12-31 $89,910 128,444
2024-09-30 $167,161 115,284
2024-06-30 $311,968 42,794
2024-03-31 $148,526 25,089
2023-09-30 $250,807 64,558
2023-06-30 $400,195 69,358
2023-03-31 $306,104 47,093
2022-12-31 $139,755 50,820
2022-09-30 $142,767 48,893
2022-06-30 $104,192 54,267
2021-06-30 $184,370 16,316
2021-03-31 $198,465 13,100
2020-03-31 $193,777 17,729